Massachusetts is home to a thriving pharmaceutical industry, with leading companies pushing the boundaries of drug discovery and biopharmaceutical advancements. From cannabinoid-based therapies by Targeted Pharmaceuticals in Worcester to oncology-focused innovations by TESARO in Waltham, these firms are at the forefront of cutting-edge research in personalized medicine and biotech. Investment opportunities abound in sectors such as oncology, neurology, and antimicrobial resistance, driven by Massachusetts' robust ecosystem of publicly traded companies and dynamic startups.
Targeted Pharmaceuticals specializes in cannabinoid-based drug discovery and personalized medicine within the pharmaceutical manufacturing industry, focusing on innovative approaches to developing tailored therapeutic solutions.
ARIAD Pharmaceuticals specializes in pharmaceutical manufacturing with a focus on oncology and innovative drug development, leveraging biotechnology to advance cancer treatments.
Cubist Pharmaceuticals specializes in pharmaceutical manufacturing, focusing on innovative solutions for infectious diseases. As a subsidiary of Merck & Co., it leverages advanced research and development capabilities to enhance treatment options in the healthcare sector.
TESARO is an oncology-focused biopharmaceutical firm dedicated to enhancing the cancer care experience through innovative drug development and commercialization. Their mission emphasizes a patient-first approach, fostering a culture of unconditional care and commitment to advancing oncology treatments.
BioXchange is a leading networking organization in the biotechnology research sector, focused on connecting individuals and companies within the life sciences community through specialized events. It leverages its extensive network to foster collaboration across various industry sectors, including pharmaceuticals and drug discovery.
Specializing in biotechnology research, Samyang Biopharm USA focuses on out-licensing innovative nucleic acid drug delivery systems and aims to establish partnerships and co-development ventures with pharmaceutical firms in the U.S.
Oxeia Biopharmaceuticals is focused on developing innovative therapeutics for mild traumatic brain injury (concussion) and related neuro-metabolic dysfunction, with a clinical-stage drug, OXE103, currently undergoing Phase 2 trials. Their unique approach addresses a significant gap in treatment options for concussion patients, emphasizing the need for more than just rest.
VDA Pharma, Inc. specializes in the manufacturing of biopharmaceuticals focused on HIV treatment, leveraging innovative approaches to develop effective therapies in the pharmaceutical industry.
NeuForm Pharmaceuticals specializes in innovative drug discovery within the biopharmaceutical sector, developing proprietary and patent-protected candidates targeting oncology, neurology, immunology, and metabolic diseases. The organization emphasizes collaboration with top academic and clinical experts to deliver best-in-class medicines to patients.
NeuroSense Therapeutics is a clinical-stage biotechnology firm dedicated to advancing innovative treatments for ALS and other neurodegenerative diseases, employing a rigorous approach through its Phase 2b clinical study. Its focus on developing groundbreaking therapies positions it at the forefront of the biopharmaceutical industry.
Sanyou Biopharmaceuticals specializes in biotechnology research, focusing on the research, development, and manufacturing of innovative biologics and reagents. Utilizing a unique 4C business model, it offers comprehensive services across the drug development lifecycle while ensuring high-quality standards through rigorous certifications.
Infinity Pharmaceuticals specializes in the development and manufacturing of innovative oncology therapies, focusing on small molecules and immuno-oncology solutions. Their commitment to advancing cancer treatment positions them as a key player in the pharmaceutical manufacturing industry.
Javelin Biotech specializes in biotechnology research, developing predictive drug discovery platforms that integrate human and computational biology to enhance preclinical drug discovery and increase drug approval rates.
Wild Biotech is a biotechnology research firm specializing in drug discovery, leveraging innovative approaches to develop resilient therapeutic solutions.
A consultancy specializing in biotechnology research and strategy, focusing on storytelling and drafting business sections for NASDAQ IPOs. Notable for its success in helping clients raise significant capital through public offerings, it offers expertise in market research and investor pitches tailored for the life sciences sector.
Immunocan specializes in biotechnology research, focusing on innovative gene-edited animal platforms for the discovery of fully human and alpaca antibodies, enhancing antibody drug R&D across diverse scenarios.
Trevie Research specializes in oncology-focused clinical development and trial management, offering expert advisory services in biopharma drug development and commercialization. The firm leverages extensive experience and strong relationships with key opinion leaders to support Phase I/II drug development programs for biotech, pharmaceutical, and non-profit organizations.
Phosphorex specializes in biotechnology research, focusing on innovative drug delivery solutions for the pharmaceutical and biopharmaceutical sectors. Their unique offerings include advanced techniques such as microencapsulation, nanosizing, and surface functionalization, enabling controlled release and targeted delivery of active pharmaceutical ingredients while enhancing solubility and bioavailability.
AP Biosciences specializes in biotechnology research by providing staffing solutions, including direct hires, contract placements, and consulting services, specifically tailored for the drug development and medical device sectors. Their consultative approach ensures optimal technical and cultural alignment, addressing a wide range of specialties such as regulatory affairs, quality assurance, and biopharmaceuticals.
A national medical specialty society dedicated to promoting best practices in pharmacovigilance, focusing on the detection and prevention of drug-related adverse effects. It offers training programs and co-sponsors conferences, catering to physicians and clinicians in the pharmaceutical and biotech industries.
The AMR Action Fund is a pioneering venture capital fund focused on advancing the development of innovative antimicrobials, including antibiotics and anti-fungals, to combat drug-resistant pathogens. By investing $1 billion to bring 2 to 4 new treatments to market by 2030, it addresses critical healthcare challenges while advocating for essential market reforms.
Kumuda specializes in biotechnology research, focusing on accelerating novel drug discovery and the development of new treatments for patients through actionable insights. Its innovative approach enhances the efficiency and effectiveness of the drug development process.
CoralBio Therapeutics specializes in biotechnology research, offering pre-clinical and in vitro assay consulting services to assist clients in drug discovery, particularly in the fields of hematology and immunology. Their innovative approach includes providing scientific validation for lead molecules targeting inflammation, thrombosis, hemostasis, and bleeding disorders.
Specializing in pharmaceutical manufacturing, Cotinga Pharmaceuticals leverages its innovative CHEMSAS artificial intelligence platform for algorithmic drug discovery and development, focusing on identifying high-potential compounds for cancer treatment through advanced predictive modeling and chemical optimization.
TAC Biopharmaceuticals specializes in biotechnology research, offering a comprehensive suite of services that support the development and commercialization of biopharmaceuticals, including generic drugs and biosimilars. With over 25 years of industry experience and a strong emphasis on regulatory expertise and strategic guidance, it empowers clients to navigate the complexities of modern medicine development.
An independent, academic research center focused on enhancing the quality and efficiency of pharmaceutical and biopharmaceutical development, regulation, and utilization through strategic information and innovative research. It serves as a vital resource for stakeholders in the industry, regulatory agencies, and public policy, while fostering dialogue on critical issues affecting drug development globally.
Kira Pharmaceuticals is a clinical-stage biotechnology firm focused on pioneering innovative therapies to address complement diseases. Utilizing its proprietary LOGIC platform, it has developed a diverse pipeline of novel treatments targeting the complement cascade, positioning itself to deliver first-in-class and best-in-class solutions in the field of immunology and oncology.
PeptiFinder Biotech specializes in biotechnology research, utilizing an innovative mRNA display platform to revolutionize drug discovery and provide cost-effective solutions for peptide optimization in early-stage development.
Xellar Biosystems specializes in biotechnology research, employing an innovative three-pronged approach to drug discovery that integrates Organ-on-a-Chip technology with artificial intelligence and machine learning. This unique methodology aims to address the complexities of human biology, significantly accelerating the drug discovery and development process.
SAGEbio LLC is focused on biotechnology research, specializing in the development of biopharmaceuticals, biologics, and biosimilars. Leveraging breakthrough technology, it aims to provide accelerated and cost-effective access to a range of biopharmaceuticals, including vaccines, particularly in the MENA region.
Updated on
Save time, improve accuracy, and get ahead of the competition with Cenco.ai.
Get startedTop 22 Web Development Companies in the US
Explore the top 22 web development companies in the US, showcasing expertise in IT, design, and finance sectors, tailored for investment professionals.
Top 26 electric power companies in the US
Discover the top 26 electric power companies in the US, highlighting their unique strengths and investment strategies in the utilities sector.
Top 21 bed bug extermination companies
Explore the top 21 bed bug extermination companies in the United States, featuring innovative solutions and specialized services to combat infestations.